Hydroxocobalamin G.L. Pharma

Hydroxocobalamin, the active ingredient in Hydroxocobalamin G.L. Pharma, is a vitamin B12 (cobalamin) presented as an injectable solution for intramuscular or subcutaneous use. It treats vitamin B12 deficiency, including pernicious anemia, and is employed as an antidote in cyanide poisoning. GNH USA supplies Hydroxocobalamin G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxocobalamin is a vitamin B12 supplement used to correct deficiency states and related disorders. - Vitamin B12 deficiency: restores normal hematologic and neurologic function. - Pernicious anemia: provides essential cobalamin for red blood cell production. - Cyanide poisoning: binds cyanide to form cyanocobalamin, facilitating detoxification.

Adverse reactions may occur following administration of hydroxocobalamin.

Common Side Effects: - Injection site pain or erythema. - Mild headache. - Nausea or vomiting. - Dizziness. - Low‑grade fever. - Transient flushing.

Serious or Rare Side Effects: - Anaphylaxis or severe hypersensitivity. - Hypotension. - Hemolysis. - Stevens‑Johnson syndrome. - Thromboembolic events. - Severe skin reactions.

Hydroxocobalamin should be used with appropriate clinical oversight. - Assess baseline B12 status: confirm deficiency before initiating therapy. - Monitor for allergic reactions: discontinue if severe hypersensitivity occurs. - Use caution in renal impairment: adjust monitoring as needed. - Avoid in patients with known cobalamin hypersensitivity. - Follow protocol for cyanide poisoning: administer under emergency guidelines. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydroxocobalamin may interact with certain medications.

Major Interactions (Avoid): - Concurrent nitrous oxide anesthesia: may exacerbate functional B12 deficiency. - High‑dose methotrexate: potential interference with cobalamin metabolism.

Moderate Interactions (Monitor Closely): - Metformin: may reduce B12 absorption; monitor levels. - Proton pump inhibitors: may impair B12 uptake; assess status. - Anticonvulsants (e.g., phenytoin): may affect B12 levels; consider supplementation.